Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies

Podobné jednotky

• The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors
  Autor: Hanny Al-Samkari, a další
  Vydáno: (2018-04-01)
• A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies
  Autor: Hanny Al-Samkari, a další
  Vydáno: (2020-06-01)
• Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature
  Autor: Gerald A. Soff, a další
  Vydáno: (2024-08-01)
• The role of romiplostim for pediatric patients with immune thrombocytopenia
  Autor: Hanny Al-Samkari, a další
  Vydáno: (2020-04-01)
• Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features
  Autor: Abraham Z. Cheloff, a další
  Vydáno: (2020-07-01)